Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Congenital anomaly
ADR ID BADD_A01016
ADR Hierarchy
03      Congenital, familial and genetic disorders
03.02      Congenital and hereditary disorders NEC
03.02.01      Congenital disorders NEC
03.02.01.001      Congenital anomaly
Description Malformations of organs or body parts during development in utero. [MeSH]
MedDRA Code 10010356
MeSH ID D000013
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Absence congenital | Anomaly anomaly congen | Anomaly congenital | Congenital | Congenital abnormality NOS | Congenital anomaly | Congenital anomaly NOS | Congenital anomaly, unspecified | Known or suspected fetal abnormality affecting management of mother | Other and unspecified congenital anomalies | Other congenital anomaly NOS | Other specified congenital anomalies | Other specified congenital anomaly | Birth defects | Minor congenital anomaly | Major congenital malformation | Non-chromosomal congenital anomaly | Congenital Abnormalities | Abnormality, Congenital | Congenital Abnormality | Deformities | Deformity | Congenital Defects | Congenital Defect | Defect, Congenital | Defects, Congenital | Abnormalities, Congenital | Birth Defects | Birth Defect | Defect, Birth | Defects, Birth
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01557Nevirapine--
BADD_D01573Nitrazepam--
BADD_D01752Phenobarbital--
BADD_D01771Pilocarpine hydrochloride--
BADD_D01777Pioglitazone--
BADD_D01791Podophyllum resin--
BADD_D01798Pomalidomide--
BADD_D01935Rifabutin--
BADD_D01961Rofecoxib--
BADD_D02192Thalidomide--
BADD_D02218Tiludronate disodium--
BADD_D02222Tinzaparin sodium--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02319Urofollitropin--
BADD_D02329Valproic acid--
BADD_D02346Venlafaxine--
BADD_D02355Vigabatrin--
BADD_D02383Zidovudine--
BADD_D02396Zonisamide--
BADD_D02397Zopiclone--
The 2th Page    First    Pre   2    Total 2 Pages